Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Opiant Pharmaceuticals Inc (OPNT)

Opiant Pharmaceuticals Inc (OPNT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 111,752
  • Shares Outstanding, K 4,400
  • Annual Sales, $ 29,630 K
  • Annual Income, $ -1,860 K
  • 60-Month Beta 0.75
  • Price/Sales 3.56
  • Price/Cash Flow N/A
  • Price/Book 2.16
Trade OPNT with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.29
  • Number of Estimates 2
  • High Estimate -0.12
  • Low Estimate -0.47
  • Prior Year 0.15
  • Growth Rate Est. (year over year) -293.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.80 +82.61%
on 08/25/21
26.00 -3.08%
on 09/21/21
+9.93 (+65.03%)
since 08/24/21
3-Month
13.02 +93.55%
on 06/25/21
26.00 -3.08%
on 09/21/21
+11.48 (+83.67%)
since 06/24/21
52-Week
6.79 +271.25%
on 10/30/20
26.00 -3.08%
on 09/21/21
+17.30 (+218.99%)
since 09/24/20

Most Recent Stories

More News
After Falling 13% in the Last Month, Should You Scoop Up Shares of Bristol Myers Squibb?

Biopharmaceuticals company Bristol Myers Squibb’s (BMY) strong clinical and operational performance and continued momentum across its product portfolio helped it generate robust revenue growth in its...

BMY : 60.23 (-0.66%)
AMRX : 5.31 (+1.92%)
RDY : 64.87 (-0.28%)
OPNT : 25.20 (-0.79%)
Watch for Continued Gains in Shares of Opiant Pharmaceuticals Inc. (OPNT)

(MENAFN - Investor Brand Network) Opiant Pharmaceuticals Inc. (NASDAQ:OPNT) traded today at a new 52-week high of $25.90. This new high was reached on above average trading volume as 949,000 shares traded...

OPNT : 25.20 (-0.79%)
Shares of Opiant Pharmaceuticals Inc. (OPNT) Rise Above Previous 52-Week High

(MENAFN - Investor Brand Network) Opiant Pharmaceuticals Inc. (NASDAQ:OPNT) traded today at a new 52-week high of $24.62. This new high was reached on above average trading volume as 949,000 shares traded...

OPNT : 25.20 (-0.79%)
Shares of Opiant Pharmaceuticals Inc. (OPNT) Rise to a New 52-Week High

(MENAFN - Investor Brand Network) Opiant Pharmaceuticals Inc. (NASDAQ:OPNT) traded today at a new 52-week high of $24.00. Approximately 949,000 shares have changed hands today, as compared to an average...

OPNT : 25.20 (-0.79%)
Opiant Pharmaceuticals Inc.: The Winning Streak Continues (OPNT)

(MENAFN - Investor Brand Network) Opiant Pharmaceuticals Inc. (NASDAQ:OPNT) traded today at a new 52-week high of $22.31. Approximately 949,000 shares have changed hands today, as compared to an average...

OPNT : 25.20 (-0.79%)
Opiant Pharmaceuticals to Participate in September Investor Conferences

Opiant Pharmaceuticals, Inc. ("Opiant") (Nasdaq: OPNT) today announced that members of the company's senior management team will participate in the following virtual investor conferences:

OPNT : 25.20 (-0.79%)
3 Under the Radar Pharmaceutical Stocks to Add to Your Watchlist

The pharmaceutical industry is expected to attract significant investor attention in the coming months as the demand for vaccines and therapies continues to soar with the resurgence of COVID-19 cases globally....

CPRX : 5.08 (+0.59%)
KMDA : 5.35 (-0.37%)
OPNT : 25.20 (-0.79%)
Opiant Pharmaceuticals Announces Second Quarter 2021 Financial Results and Provides Corporate Update

Opiant Pharmaceuticals, Inc. ("Opiant") (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat addictions and drug overdose, today reported financial results for the three and...

OPNT : 25.20 (-0.79%)
Opiant Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5, 2021

Opiant Pharmaceuticals, Inc. ("Opiant") (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today announced it will report its financial results for...

OPNT : 25.20 (-0.79%)
Opiant Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Opiant Pharmaceuticals, Inc. ("Opiant") (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat addictions and drug overdose, today announced, as required by Nasdaq Stock Market...

OPNT : 25.20 (-0.79%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Opiant Pharmaceuticals, Inc. is a specialty pharmaceutical company. It is engaged in developing opioid antagonist treatments for substance use, addictive and eating disorders. Opiant Pharmaceuticals Inc., formerly known as Lightlake Therapeutics, Inc., is based in New York.

See More

Key Turning Points

3rd Resistance Point 27.24
2nd Resistance Point 26.62
1st Resistance Point 25.91
Last Price 25.20
1st Support Level 24.58
2nd Support Level 23.96
3rd Support Level 23.25

See More

52-Week High 26.00
Last Price 25.20
Fibonacci 61.8% 18.66
Fibonacci 50% 16.39
Fibonacci 38.2% 14.13
52-Week Low 6.79

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar